Pigment gallstone pathogenesis: slime production by biliary bacteria is more important than beta-glucuronidase production.
Pigment stones are thought to form as a result of deconjugation of bilirubin by bacterial beta-glucuronidase, which results in precipitation of calcium bilirubinate. Calcium bilirubinate is then aggregated into stones by an anionic glycoprotein. Slime (glycocalyx), an anionic glycoprotein produced by bacteria causing foreign body infections, has been implicated in the formation of the precipitate that blocks biliary stents. We previously showed that bacteria are present within the pigment portions of gallstones and postulated a bacterial role in pigment stone formation through beta-glucuronidase or slime production. Ninety-one biliary bacterial isolates from 61 patients and 12 control stool organisms were tested for their production of beta-glucuronidase and slime. The average slime production was 42 for biliary bacteria and 2.5 for stool bacteria (P <0.001). Overall, 73% of biliary bacteria and 8% of stool bacteria produced slime (optical density >3). In contrast, only 38% of biliary bacteria produced beta-glucuronidase. Eighty-two percent of all patients, 90% of patients with common bile duct (CBD) stones, 100% of patients with primary CBD stones, and 93% of patients with biliary tubes had one or more bacterial species in their stones that produced slime. By comparison, only 47% of all patients, 60% of patients with CBD stones, 62% of patients with primary CBD stones, and 50% of patients with biliary tubes had one or more bacteria that produced beta-glucuronidase. Most biliary bacteria produced slime, and slime production correlated better than beta-glucuronidase production did with stone formation and the presence of biliary tubes or stents. Patients with primary CBD stones and biliary tubes had the highest incidence of slime production. These findings suggest that bacterial slime is important in gallstone formation and the blockage of biliary tubes.
Stewart
L
L
Department of Surgery, University of California, San Francisco and San Francisco VA Medical Center, San Francisco, CA 94121, USA.
Ponce
R
R
Oesterle
A L
AL
Griffiss
J M
JM
Way
L W
LW
D001419:Bacteria / Q000201:enzymology*; D001659:Biliary Tract / Q000382:microbiology*; D002769:Cholelithiasis / Q000201:enzymology / Q000209:etiology* / Q000382:microbiology / Q000503:physiopathology; D005243:Feces / Q000382:microbiology; D005260:Female; D042882:Gallstones / Q000201:enzymology / Q000382:microbiology; D005966:Glucuronidase / Q000096:biosynthesis*; D006801:Humans; D008297:Male; D008875:Middle Aged
D005966:Glucuronidase